chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 13-MAR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23  0.5ml (lot # K012424, expiration date 05-JUN-2016). This specified lot number vaccine was exposed to temperature excursion twice.  The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of -1 Fahrenheit degree. The total cumulative excursion time of the second time was 48 hours with the lowest recorded temperature of 0 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
mom reported swelling & numbness down lt arm to lt wrist & hand including fingers starting @ 145PM; adeq ROM noted to lt arm, wrist, hand & finger; mod amt of swelling noted to lt wrist, hand; MD does not think react was from inject
Attending Physician: (Privacy)DO Specialty:Internal Medicine Date of H&P: 2/3/2022    HPI:   This is a 44y.o. male with history of HTN and DM, presents to the emergency department w swelling, erythema, and a wound to the right foot that started over the past weekend and it is progressively gotten worse.  He denies any trauma    He notes an area of pus between the first and second toe.  Sometimes the pain does radiate up to his calf.  He denies any associated HA, dizziness, or CP.  Patient states over the past week he has had chills, rhinorrhea, nonproductive cough, generalized malaise, and anorexia.  When his foot pain started he thought that symptoms were secondary to that, but patient tested positive for Covid?19 upon arrival to the ER.  He denies any known exposure, sick contacts, or recent travel. He is covid vax x 2. Yet to be boostered.
Information has been received from a 72 year old female consumer with type 2 diabetes mellitus, high cholesterol, high blood pressure, osteoarthritis, penicillin allergy and sulfonamide allergy who on an unspecified date was vaccinated with her first dose of PNEUMOVAX 23 (manufacturer unknown). Her arm swelled, hurt, and was infected from her shoulder to her wrist. She was given antibiotics as treatment. On 19-OCT-2009 she was vaccinated with another dose of PNEUMOVAX 23 (manufacturer unknown), and was hospitalized on 20-OCT-2009 for the same symptoms from her shoulder to elbow. The patient had the following laboratory tests done: blood work, ultrasound of arm, echocardiogram, electrocardiograms and a computed axial tomography (results not reported). While admitted she received clindamycin, vancomycin and CIPRO. Upon discharge (25-OCT-2009) she was given doxycycline. The patient recovered on an unspecified date. Additional information has been requested.
first dose administered January 18, 2020 / wants to know how to proceed with the second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 18th January 2020, about a year and half ago.).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that, the patient wanted to proceed with 2nd dose of Shingrix. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The VAERS details were reported for 1st dose. The reporter consented to follow up.
Received primary smallpox on 2/23/03-L arm. 3/4/03 began fever, chills, body aches worsening HA, mild photophobia, generalized vesicular rash, mild cough, generalized adenopathy in L hand site without s/s of infiltration. 20qTV NS 1000 ccs BP 115/60 P 16 HR 79 temp 98.6.
Woke with headache . by 1:30pm had a fever, 101.7, chills, headache all day. Lasted until about 9pm.
The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included fexofenadine (ALLEGRA) and rabeprazole from unknown dates for unknown indications. On 17Apr2021, 24 hours after the vaccine, the patient experienced shaking and chills. She was feeling fatigued. The patient slept for 3 hours, woke up around 20:00 on 17Apr2021, and had severe allergy attack all night even though allergy medications were taken. No medications were working. She had symptoms such as severe nasal congestion, sinus pressure, difficulty breathing after using inhaler, burning throat and nasal passages, shortness of breath. It was the worst allergy attack she had ever had. It felt like her immune system shut down and was reacting to everything she was allergic to on a large scale. The patient reported she did not receive any treatment for the events. The outcomes of shaking, chills, severe nasal congestion, sinus pressure, difficulty breathing, burning throat and nasal passages, and shortness of breath were not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of 12 months old infant patient and unknown gender. On 02-SEP-2014 the patient was vaccinated with a dose of MMRII (lot H020255, expiration date not reported) (dose, route, were not reported). No adverse effect was reported. The outcome of events reported was unknown. No product quality complaint was involved. This is one of several reports received from the same source. Additional information has been requested.
Tinnitus with loud ringing in the head. Ongoing. I have tried to find a solution to this distressing situation but nothing works to date. Additionally, (following the tinnitus onset) I have been diagnosed with hearing loss and have been prescribed hearing aids, which I wear religiously. Unfortunately they do not address the tinnitus symptoms.
Swollen right eye, Blurred impaired vision. Pressure behind the eye. Headaches
The inoculations occurred on 02/27/21 and 03/27/21.  The Lot number for Dose1 was 001A21A.  The Lot number for Dose2 was 025A21A.  A mutual friend of the decendent is/was an employee of hospital.  The deceased was a high BMI, male with a prior history having a stroke that resulted in comatose about ten years ago prior to inoculation with two doses of Moderna.  During a martial arts training session the victim had a stroke.  He was transported to hospital.  He was placed on life support.  A few days later life support was withdrawn.  At his funeral his jiujitsu instructor stated he had a heart attack prior to the stroke event.  I am not aware if the heart attack occurred before or after inoc
The patient began to experience fever and chills within a few hours of receiving the vaccine that continued for approximately 2 hours. The patient used Tylenol 8 hour to help with the fever that seemed to help.
Per patient history, he developed left elbow pain onset "immediately" following receipt of AVA #6, SC, left arm, in May 2007; denied hx trauma or overuse; joint pain was not accompanied with swelling, erythema, warmth; did not recall presence of large local injection site reaction or any other systemic symptoms; diagnosed with lateral epicondylitis Nov 2007; previous history of bilateral hip pain, onset associated with receipt of AVA doses #1-5 from 1999-2000.  Symptoms: Joint Pain, isolated, left elbow.
chills, body aches, tired, headache, loss of appetite, nausea, dizzy  (time course approximately - chills started on Friday, 10/08/2021 approximately 10 am; chills, achy, and headache subsided Saturday  AM10/09/2021; nausea /loss of appetite susbsided Sunday, 10/10/201 around 7 pm.
It was reported that a pt rec'd TD adult vaccination on 3/20/00. Reportedly on 3/24/00, the pt developed a local reaction of redness, warmth, induration.
7 days after receiving the COVID-19 vaccine in my upper left arm, the area began to feel hot to the touch, is red, tight, sore, and swollen. I am completing this report 18 hours after onset of reaction, and the symptoms remain the same, and do not appear to be worsening or improving. In addition to the injection site issue, I've experienced fatigue and headache over the past 18 hours, which seems to come and go.
got her 1st dose of the Pfizer Covid Vaccine in her right deltoid. About 1 hour after she got her vaccine she developed a tremor in her left hand/forearm. It was most vigorous when she would reach her hand toward her mouth, elbow bent. I would have her straighten her arm and hold if firm to stop it while massaging the muscles in her right forearm and bicep area. She continued to move her arms and massage her left arm, bending and straightening. Her hand would vigorously shake when she reached her hand toward her mouth.  This went on for about one hour and then gradually became less vigorous and then went away completely.
C/O + nausea, lightheadedness 4" after receiving injection. Placed in supine position, monitored vital signs and gave po fluids.
Bursitis; acute case of bronchitis and laryngitis; Frozen shoulder in non vaccinated arm; Severe brain fog; Recently developed an acute case of bronchitis I was never sick before being treated for walking pneumonia; Dizziness; Dizziness Vertigo; Six days after each vaccine I experienced exhaustion I slept for two days; Headache; body ache; Fatigue extreme; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Dizziness Vertigo), FEELING ABNORMAL (Severe brain fog), BRONCHITIS (Recently developed an acute case of bronchitis I was never sick before being treated for walking pneumonia), DIZZINESS (Dizziness) and BURSITIS (Bursitis) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D NOS, MAGNESIUM, FISH OIL, ESCITALOPRAM OXALATE (LEXAPRO), BUPROPION, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and BUTALBITAL, CAFFEINE, PARACETAMOL (FIORICET) for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced VERTIGO (Dizziness Vertigo), DIZZINESS (Dizziness), FATIGUE (Six days after each vaccine I experienced exhaustion I slept for two days), HEADACHE (Headache), MYALGIA (body ache) and FATIGUE (Fatigue extreme). On an unknown date, the patient experienced FEELING ABNORMAL (Severe brain fog), BRONCHITIS (Recently developed an acute case of bronchitis I was never sick before being treated for walking pneumonia), BURSITIS (Bursitis), LARYNGITIS (acute case of bronchitis and laryngitis) and PERIARTHRITIS (Frozen shoulder in non vaccinated arm). On 17-Feb-2021, VERTIGO (Dizziness Vertigo), DIZZINESS (Dizziness), FATIGUE (Six days after each vaccine I experienced exhaustion I slept for two days), HEADACHE (Headache) and MYALGIA (body ache) had resolved. At the time of the report, FEELING ABNORMAL (Severe brain fog) had resolved, BRONCHITIS (Recently developed an acute case of bronchitis I was never sick before being treated for walking pneumonia), BURSITIS (Bursitis), LARYNGITIS (acute case of bronchitis and laryngitis) and PERIARTHRITIS (Frozen shoulder in non vaccinated arm) outcome was unknown and FATIGUE (Fatigue extreme) was resolving.            No treatment medication were provided by the reporter   This case was linked to MOD-2021-289558 (Patient Link).
Information has been received from a physician concerning a 60 year old male who on 07-JAN-2008 was vaccinated IM in the left arm with a dose of pneumococcal 23v polysaccharide vaccine, lot #658200/0804U. On 07-JAN-2008, after receiving the injection, the patient experienced pain and redness at and below the injection site. Medical attention was sought. His outcome was not reported. Additional information has been requested.
Excessive swelling from injection site, around front of arm to lymph node in arm pit. Excessive body fatigue. Sore throat lasting three days, mild fever 800 mg Motrin, 1000 mg Tylenol, Benadryl. Suspect infection (vs vigorous take).
become deathly ill; Initial information was received on 13-Nov-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional.  This case involves a patient (demographics unknown) who become deathly ill (illness), when received INFLUENZA VACCINE.  It is unknown if the patient had any medical history, concomitant disease or risk factor  Medical treatment(s), past vaccination(s) and family history were not provided    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient become deathly ill (illness) (unknown latency, non-serious event) following the administration of INFLUENZA VACCINE.  It is unknown if the patient experienced any additional symptoms/events.  There were no lab data/results available   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case
Information has been received from a licensed practical nurse (LPN) concerning a 8 weeks old patient of unknown gender. The patient's pertinent medical history, drug reactions, allergies or concurrent conditions were not reported. On 06-JUN-2016, the patient was vaccinated with an improperly stored dose of ROTATEQ administered orally for prophylaxis (lot number M004508 with an expiration date of 29-JUN-2017) (dose was not reported). Then, on 15-SEP-2016, the patient was also vaccinated with another improperly stored dose of ROTATEQ administered orally for prophylaxis (lot number M019708 with an expiration date of 25-OCT-2017) (dose was not reported). Other suspect and concomitant medications were not provided. There was no adverse effect reported. The  temperature excursion reported was 1 degree Celsius (C) for 48 hours for both doses. A digital data logger was involved. There were no previous temperature excursions. This is one of several reports received from the same reporter. Additional information is not expected as all follow up information has been received. Sender's Comments: US-009507513-1610USA013756.
24 hours after gardisil feels unwell with abdominal pain, ackey, sore decresed energy lasting approx 1 to 2 days
This case was reported by a physician via call center representative and described the occurrence of myoclonic jerks in a male patient who received ENGERIX B (batch number 2KJ42, expiry date unknown). On an unknown date, the patient received ENGERIX B. On an unknown date, unknown after receiving ENGERIX B, the patient experienced myoclonic jerks, mental status changes and fever. On an unknown date, the outcome of the myoclonic jerks, mental status changes and fever were unknown. It was unknown if the reporter considered the myoclonic jerks, mental status changes and fever to be related to ENGERIX B. Additional details were provided as follows: The age at vaccination was not reported. The hepatitis B vaccine was administered to a healthy patient other than having pacemaker. The patient experienced myoclonic jerks, altered mental status and high fever.
Case number PHEH2016US023415 is an initial spontaneous report received from a nurse on 13 Sep 2016. This report refers to a 51 year old patient whose gender was not specified. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1515701) at a dose of 0.5 ml intramuscularly in the left arm on 29 Apr 2016. It was reported that the patient received FLUVIRIN multi dose vial (MDV) that had been exposed to 8 to 10 temperature excursion. The patient did not experience any adverse events following vaccination.
15 month old male with a past medical history significant for HLHS s/p glenn, pulmonary hypertension, pleural effusion, and G tube dependence who received MMR, PCV13, and varicella vaccines at Clinic. Developed cough, rash, hives, and facial angioedema in the waiting room (unsure how quickly).He received 2x IM epinephrine, EMS was called, and patient transferred to hospital. Patient received diphenhydramine and transferred to the PICU for monitoring. The patient returned to baseline and discharged the next morning.
On 17 APR 12 patient c/o chest pain sent to ER. Patient states she had a heart cath - was admitted to telemetry.
Information has been received from a certified medical assistant concerning a 20 year old male with a history of respiratory tract infection who on 20-DEC-2006 was vaccinated SC with a 0.5 mL dose of Pneumovax 23 (Lot# 655291/0985F).  Concomitant vaccination on 20-DEC-2006 included a dose of influenza virus vaccine (unspecified) and AUGMENTIN.  On 21-DEC-2006 the patient experienced an 8 centimeter area that was red, warm and swollen and had a temperature of 101.  It was reported that the patient was recovering.  The patient sought unspecified medical attention.  Additional information has been requested.
pt recv vax; many hives, inc T & edematous hands,feet & face p/ vax;
Information has been received from a pharmacist concerning a 34 year old Native American female with asthma and urticaria (dx'd at visit on 1/22/02) and allergies to acetaminophen (+) propoxyphene Napsylate (Darvocet), loratadine (Claritin) and doxycycline who on 1/22/02, at 11:00 AM, was vaccinated IM, in the left deltoid, with pneumococcal vaccine 23 polyvalent (lot 641116/1160L). Concomitant medication included estrogens conjugated (Premarin), cyproheptadine hydrochloride (Periactin), flunisolide (Aerobid) and albuterol. It was reported that the pt experienced an anaphylactic reaction. The symptoms onset at the pt's home and she went to the local ER. The symptoms were described as severe swelling on the left side of her face and lips and excessive tearing in her eyes. She was treated in the ER with epinephrine and steroids and released. The symptoms resolved the same day. Another pt (WAES 0201USA03094) experienced swelling, redness and warmth at the injection site after vaccination with the same lot. The reporter "questioned the stability" of the lot. The records of testing prior to release of this lot have been checked by GMP Compliance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Anaphylactic reaction was considered to be an "Other Important Medical Event".
Pt recv vax on 10/21/98; 2 hr post vax pt exp dizziness, elevated blood pressure, rushing feeling, crawling skin,
I received the second dose on July 26, 2021. I developed hives on 10/18/2021. I saw a doctor and was prescribed steroid medication.
Information has been received from a pharmacist referring to unspecified patients of unknown age and gender. The patient's medical history, concomitant therapy and drug reactions were not reported. The primary reporter reported that improperly stored doses of ZOSTAVAX (lot # L029484, expiry date 06-NOV-2016, lot # L032184, expiry date 25-NOV-2016) were administered to unspecified patients. One unspecified patient received ZOSTAVAX (lot # L032184, expiry date 25-NOV-2016) on 22-DEC-2015 and two unspecified patients received ZOSTAVAX (lot numbers unspecified) on 21-JAN-2016. The ZOSTAVAX was exposed to 40 Fahrenheit for 912 hours (38 days). Back in range was reported as "Yes". There was no previous temperature excursion. No adverse effects were reported. Additional information has been requested.
Screaming episodes and marked irritability - started several hours after the vaccine and lasted for 8 days.
shivering Narrative:  Patient with recent COVID infection on 1/15/21 and is now residing in the long term care facility for strengthening post severe COVID infection. Patient received his first dose of the COVID vaccine on 2/9/21. The same afternoon that patient receive his COVID vaccine, RN documents 3 "bug bit" raised areas on patient's right forearm (same arm in which he received his COVID vaccine). RN documents that patient's right arm was tender and slightly warm at the injection site. On 2/10/21, the day after COVID vaccine administration RN reports patient was feeling poorly and experiencing chills, shivering, and achy. RN note states that patient had a fever of 101.3 and Tylenol was administered to treat.
Patient states she feels dizzy, lightheaded,  and SOB. EMS was called and was checked out by EMS personnel. Both parents were present during the incident..
I've previously been vaccinated with two Moderna shots. This dose was Pfizer.   I noticed first thing when I woke up let my heart rate was elevated. It has continued to be elevated throughout the day. My usual resting heart rate is 70 beats per minute, but I can get up to 80 or 90 beats per minute when I'm sitting on my stool at work. Today my he was between 120 and 130 while sitting on my stool at work.   While standing today, it has been about 140. I've had no shortness of breath, no chest pain. When I checked my blood pressure this afternoon it was 144 over 87 and my pulse was 127. For reference, I've never had a blood pressure reading higher than 120 / 80.
Tingling sensation in throat after Hepatitis B shot.  No shortness of breath.  Medrol dose pack 1, over the counter Benadryl.  Patient called 06/15/2005 - Blotchy arm, flu like symptoms was advised by RN to follow up in ER.
Swelling at vaccination site, became flushed, had hives on hands, face, neck, chest & body hives.
blisters; pain (due to shingles); This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (pain (due to shingles)) and BLISTER (blisters) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and Heart attack.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced HERPES ZOSTER (pain (due to shingles)). On 22-Feb-2021, the patient experienced BLISTER (blisters). At the time of the report, HERPES ZOSTER (pain (due to shingles)) and BLISTER (blisters) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
On 04/19/2022, Resident received 4th dose of COVID-19 vaccine, Pfizer, at 10:00am in right upper arm. Resident was stable and tolerated well. All vitals stable. At 9am on 04/20/2022, resident complained of pain to B/L upper and lower extremities, appeared to be short of breath and had pain when breathing. Edema noted to bilateral lower extremities with new onset of confusion. Blood pressure 187/123, HR 130, O2 93% on room air, RR 20. Resident transferred to Hospital for evaluation. Outcome unknown at this time.
vaccine was administered on 11/4/22 after the beyond use date of 11/02/2022